Get the full Desentum Oy company profile
Access contacts, investors, buying signals & more
Desentum Oy, a Finnish clinical-stage biopharmaceutical company, has raised $31.5M from Springvest Oyj.
The company develops allergen immunotherapy products designed to switch the immune system's response to allergens from hypersensitivity to tolerance, with the goal of providing long-term relief from allergic symptoms after only a few months of treatment. Its product development targets both respiratory and food allergens.
Desentum raises €28 million to develop safer, more effective allergen immunotherapy - Desentum Desentum, a Finnish clinical-stage biopharmaceutical company, has closed an oversubscribed €28 million equity round to advance its allergy immunotherapy programmes.
The round, arranged by Finnish investment firm Springvest, is one of the largest ever raised by a privately held Finnish drug development company. Desentum is developing a new type of allergen immunotherapy based on genetically engineered allergens. If successful, it could benefit hundreds of millions of people. Allergies are becoming more common, and in Europe alone more than 150 million people l
Fintoil
Fintoil's new, state-of-the-art biorefinery in Hamina, Finland, refines Crude Tall Oil to products for its customers in biofuels, adhesives, tackifiers, health, wellness, and many other industries.
$118.2M Unknown
5 days ago
Mallow
Mallow is a highly specialized Microsoft Azure consultant, that helps our clients travel across the cloud. Our Azure professionals help our customers to take full advantage of cloud capabilities for strategic and business driven development. We advise on cloud and business-related solution development and consult on design & delivery of new cloud native solutions. Our people are some of the most experienced Azure professionals around, well-known and respected among clients and peers alike. Part of Reaktor Group, offering local Azure capability, proven by certifications and backgrounds with Microsoft, top Microsoft partners and deliveries for multiple Finnish and international customers.
$12.4M Seed
7 days ago
Largest funding rounds in Biotechnology on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Shockwave Medical United States | Unknown | $13.1B | 2y ago |
| 2 |  NeuroEM Therapeutics United States | Unknown |
Companies that recently closed a Unknown round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Skylo United States | Unknown | $23.1M | today |
| 2 |  Monopulse ApS Denmark | Unknown | $2.2M | today |
| $7.2B |
| 2y ago |
| 3 |  GRAIL United States | Unknown | $7.1B | 2y ago |
| 4 |  Illumina United States | Unknown | $7.1B | 2y ago |
| 5 |  RemeGen Biosciences United States | Grant | $5.6B | 9mo ago |
| 3 |
 Crowdworks AI |
| Unknown |
| $838.4K |
| today |
| 4 |  CameraMatics Ireland | Unknown | $55.2M | today |
| 5 |  Tessolve Semiconductor Pvt. Ltd. | Unknown | $75.0M | today |
Contacts, investors, buying intent signals & tech stack.
Trusted by 200+ sales teams
Springvest Oyj
Reach Desentum Oy's investors directly from your dashboard.
Start free trial
Bespoke Labs ⚡
Recently received
Quantum Genomics
Recently received
Circular Materials
Recently received
